Decrease in the concentrations of transforming growth factor-beta 1 in the sera of patients with Kawasaki disease

Scand J Rheumatol. 1997;26(4):314-7. doi: 10.3109/03009749709105322.

Abstract

Kawasaki disease (KD) is one of the most important forms of vasculitis, and is characterized by the initiation of a proinflammatory cytokine cascade. To further characterize the immunological profile of KD, we measured the serum levels of transforming growth factor-beta 1 (TGF-beta 1) as a regulatory cytokine. We determined the concentration of TGF-beta 1 in the sera of the patients with KD, anaphylactoid purpura (AP), and scarlet fever, using a sandwich enzyme linked immunosorbent assay. The serum levels of TGF-beta 1 were decreased in patients with KD, but not in patients with AP or scarlet fever during the acute stage. We found an inverse correlation between TGF-beta 1 and soluble tumor necrosis factor (TNF) receptor levels in KD patients during the acute and subacute stage. Decreased levels of TGF-beta 1, in particular to suppress TNF alpha (TNF-alpha) production, is an important part of the regulatory system of increased TNF-alpha production which cause vasculitis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Child
  • Child, Preschool
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Humans
  • IgA Vasculitis / blood
  • Infant
  • Male
  • Mucocutaneous Lymph Node Syndrome / blood*
  • Receptors, Tumor Necrosis Factor / metabolism
  • Scarlet Fever / blood
  • Transforming Growth Factor beta / blood*
  • Tumor Necrosis Factor-alpha / analysis

Substances

  • Receptors, Tumor Necrosis Factor
  • Transforming Growth Factor beta
  • Tumor Necrosis Factor-alpha